09-23-04

Sopherion Therapeutics Raises $47M in Series B Funding and Acquires North American Rights to Myocet™

       
 
 

 

 

Sopherion Therapeutics, Inc.
104 Carnegie Center, Suite 200
Princeton, NJ 08540

609-986-2021 (t)
609-986-2036 (f)

 
 

Terms and Conditions
Copyright © Sopherion Inc. All rights reserved.

The materials on these web pages are copyrighted by Sopherion Therapeutics, Inc. Please respect the rights of Sopherion Therapeutics, Inc. Permission is given to view the material on the Sopherion Therapeutics Inc. web pages and save that material only for your further personal and non-commercial reference but do not further copy, modify, use or distribute the material in any way unless you obtain the permission of Sopherion Therapeutics, Inc.